Patents by Inventor Martha K. Newell

Martha K. Newell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110206755
    Abstract: The invention is based in part on the discovery that uncoupling proteins (UCPs) are expressed in the plasma membrane of rapidly dividing cells but not of growth arrested, chemotherapy resistant cells. It has also been found according to the invention that UCP is expressed in the lysosomal membrane under certain metabolic conditions. Thus the invention is methods, products, screening assays and kits relating to the manipulation of UCP expression within cellular and intracellular membranes.
    Type: Application
    Filed: October 19, 2010
    Publication date: August 25, 2011
    Applicant: The University of Vermont and State Agricultural College
    Inventor: Martha K. Newell
  • Patent number: 7105718
    Abstract: The invention relates to methods and products for manipulating plant metabolism and resistance to infection.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: September 12, 2006
    Assignee: The Regents of the University of Colorado
    Inventors: Martha K. Newell, Sandra L. Berry-Lowe
  • Publication number: 20030150022
    Abstract: The invention relates to methods and products for manipulating plant metabolism and resistance to infection.
    Type: Application
    Filed: March 30, 2001
    Publication date: August 7, 2003
    Inventors: Martha K. Newell, Sandra L. Berry-Lowe
  • Publication number: 20030138433
    Abstract: The invention relates to methods and compositions for promoting antigen-specific immune responses with an appropriate cytokine bias. More specifically, the present invention relates to methods of using autologous adoptive immunotherapy with antigen-specific, ex vivo-primed T cells or B cells to promote antigen-specific immune responses with a Th1 or Th2 cytokine bias.
    Type: Application
    Filed: August 21, 2002
    Publication date: July 24, 2003
    Inventors: Martha K. Newell, William F. Wade
  • Patent number: 6582713
    Abstract: The present invention provides methods and compositions for promoting wound healing and reducing scar formation. In particular, the present invention provides cyanoacrylate polymer sealants formulated to contain biologically active elemental silver and/or insulin. The invention also provides methods and compositions for delivering silver and/or insulin in combination with cyanoacrylate sealants. In particular, the present invention provides methods and compositions suitable for treatment of wounds in diabetics, normal patients and surgical patients.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: June 24, 2003
    Assignees: Univ. of Colorado - Colorado Springs, Medlogic Global Corp., Anodose Dermal Product, Inc.
    Inventors: Martha K. Newell, Ian Askill, Javin Pierce, William Crisp
  • Publication number: 20020122787
    Abstract: The present invention provides methods and compositions for promoting wound healing and reducing scar formation. In particular, the present invention provides cyanoacrylate polymer sealants formulated to contain biologically active elemental silver and/or insulin. The invention also provides methods and compositions for delivering silver and/or insulin in combination with cyanoacrylate sealants. In particular, the present invention provides methods and compositions suitable for treatment of wounds in diabetics, normal patients and surgical patients.
    Type: Application
    Filed: March 30, 2001
    Publication date: September 5, 2002
    Inventors: Martha K. Newell, Ian Askill, Javin Pierce, William Crisp